Tag: misinformation
Top News
Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity...
Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.
- Our Sponsors Ad -
